TYK Medicines, Inc
Registry sponsor category
Industry
- Other names
- TYK Medicines, Inc
- Company name
- TYK Medicines, Inc
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (17)
- [14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects
- A Study of TY-1091 in Patients With Advanced Solid Tumors
- A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
- A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
- A Study of TY-302 in Patients With Advanced Solid Tumors
- A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation
- A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
- A Study of TYK-00540 in Adult Patients With Solid Tumors
- A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers
- Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
- Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects
- Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
- Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
- Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
- Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
- Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors
- TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases